Medical Condition News

RSS

Study reveals how clotting protein and blood platelets promote immune evasion, tumor progression

A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute reveals how a clotting protein and blood platelets can promote cancer progression and suppress immune responses to cancer.

14 Jan 2020

Biomaterial-based vaccine has potential to completely eliminate AML cells

Acute myeloid leukemia (AML) is a deadly blood cancer that originates in the bone marrow and kills most of its victims within five years. Chemotherapy has been the standard AML treatment for over 40 years, and while it often causes the cancer to go into remission, it rarely completely eliminates the cancerous cells, which then lead to disease recurrence in nearly half of treated patients.

14 Jan 2020

Study shows how treatment resistance develops in patients with bile duct cancer

A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute shows how resistance to a promising targeted drug develops in patients with a rare, lethal cancer of the bile ducts called cholangiocarcinoma.

14 Jan 2020

Scientists discover powerful molecule that explains why people with anxiety use marijuana

/news/20200113/Research-could-help-explain-why-some-people-use-marijuana-when-stressed-or-anxious.aspx

14 Jan 2020

Rapid diagnosis centers cut waiting times for patients with non-specific symptoms

A rapid diagnosis centre has cut waiting times for patients with non-specific symptoms who may have cancer from 84 days to 6, and costs less than current usual care if used at more than 80% of capacity, a new study by Swansea University researchers and NHS colleagues has shown.

14 Jan 2020

AI replaces prick test to detect blood sugar levels

Tracking fluctuations in blood glucose levels is crucial for monitoring diabetic patients. Strict glucose monitoring reduces the risk of hypoglycemia, which can be potentially fatal if it’s not treated promptly.

14 Jan 2020

ASN's new Kidney Care First Model Calculator available for nephrologists

The American Society of Nephrology has developed a Kidney Care First (KCF) Model Calculator, a tool that will help nephrologists anticipate how their practices might perform if they choose to participate in the new payment program.

14 Jan 2020

Tailored mesoporous silica particles could be used to treat obesity, diabetes

Engineered ingestible molecular traps created from mesoporous silica particles (MSPs) introduced to the gut can have an effect on food efficiency and metabolic risk factors. The results from studies on mice, published in Nanomedicine, demonstrate the potential to reduce the energy uptake into the body and could lead to new treatments for obesity and diabetes.

14 Jan 2020

Exosome treatment promotes remarkable stroke recovery in swine models

It's been almost a quarter century since the first drug was approved for stroke. But what's even more striking is that only a single drug remains approved today.

14 Jan 2020

Common misconception about asthma has negative impact on people with severe disease

People living with a severe form of asthma are not receiving the support they need because the condition is not taken seriously enough, according to new research.

14 Jan 2020

Gut bacteria could protect against Parkinson’s, research suggests

A common bacteria that boosts digestive health can slow – and even reverse – build-up of a protein associated with Parkinson’s, new research suggests.

14 Jan 2020

Orthopaedic Research UK announces £140,000 investment in biotech startup

Orthopaedic Research UK has announced that biotech startup, Renovos, will receive the first investment from its newly launched the Ronald Furlong Fund, a partnership between ORUK and HS., established this year in memory of the charity’s founder.

14 Jan 2020

Boehringer Ingelheim and Enleofen partner to develop anti-IL-11 therapies for multiple fibrotic disorders

Boehringer Ingelheim and Enleofen Bio Pte. Ltd. announced today the acquisition of worldwide exclusive rights to Enleofen’s preclinical interleukin-11 (IL-11) platform by Boehringer Ingelheim to develop first-in-class therapies across a broad range of fibro-inflammatory diseases.

From Boehringer Ingelheim International GmbH 14 Jan 2020

Researchers evaluate epinephrine use for treatment of pediatric OHCA

A loved one suffering cardiac arrest is an emotionally stressful time for families, but never more so than when the patient is a child. The very real potential for loss of life in these situations means that the way in which emergency responders treat out of hospital cardiac arrest (OHCA) becomes even more crucial when dealing with pediatric patients.

14 Jan 2020

Daily chronic pain, opioid use disorder add to the challenges of relieving pain among patients

The combination of more Americans reporting daily chronic pain and the rapidly increasing prevalence of opioid misuse and opioid use disorder (OUD) adds to the challenges of relieving patients' pain effectively and safely.

14 Jan 2020

Discovery could lead to new treatments for hypertension, dementia

A study led by researchers at UCL has discovered the mechanism that allows the brain to monitor its own blood supply, a finding in rats which may help to find new treatments for human conditions including hypertension (high blood pressure) and dementia.

14 Jan 2020

Study may help develop new treatments for abnormal nerve growth in the spine

In experiments with genetically engineered and old mice, Johns Hopkins Medicine researchers say they have added to evidence that the vast majority of low back pain in people may be rooted in an overgrowth of pain-sensing nerves into spinal cartilaginous tissue.

14 Jan 2020

Researchers find key to preventing muscular dystrophy-related heart disease

A Rutgers-led team may have found the key to preventing Duchenne muscular dystrophy (DMD)-related heart disease, the leading cause of death in patients living with the disease.

14 Jan 2020

A New Discovery about MAIT Cells Sheds Light on Early-Phase HIV Infection

Researchers at the Karolinska Institutet, Sweden, have made an important discovery about a poorly understood group of immune cells (mucosa-associated invariant T [MAIT]cells) that could improve understanding of what happens during the initial stages of HIV infection.

14 Jan 2020

Increased Vegetable Intake Fails to Slow Prostate Cancer Progression, Study Finds

Researchers in the United States have conducted a study investigating whether a telephone-based interventional program encouraging an increased intake of vegetables would slow disease progression among patients with early-stage prostate cancer.

14 Jan 2020